HOME >> MEDICINE >> NEWS
Work on promising inorganic blood substitute to move forward with $1.5 million grant from NIH

nt circulation remains to carry the bubbles to the lungs, they can pick up oxygen and deliver it to tissues.

Nearly all other blood substitutes currently in use or in development are based on hemoglobin, the iron molecule that carries oxygen. Hemoglobin products are expensive and can cause hypertension, Lundgren said. Moreover, they raise some of the same concerns associated with any blood product, and can't be used in persons who refuse transfusion for religious or other reasons.

DDFPe circumvents all the hazards associated with the use of blood products and is 500 times more effective than other fluorocarbon-based blood substitutes, Lundgren said. "We know that if it is administered soon after blood loss, the product has a dramatic effect. Very small amounts introduced into the circulation of a pig after severe blood loss can save the animal from hemorrhagic shock."

His current research will concentrate on finding out how soon the treatment must occur after bleeding begins. The goal is to postpone collapse of the circulatory system during severe blood loss for at least four hours. Researchers will gather physiological and biochemical data relating to the effects of severe blood loss on organs and tissues throughout the investigation.

"Our findings should help to lay a solid foundation for pursuing FDA approval for human use of this blood substitute," Lundgren said. "In the best of circumstances, it would be carried in every ambulance."
'"/>

Contact: Lois Baker
ljbaker@buffalo.edu
716-645-5000 x1417
University at Buffalo
15-Apr-2004


Page: 1 2

Related medicine news :

1. Another look finds promising proteomics test is not biologically plausible
2. Inflammatory cells highly promising target in NF 1
3. Drug treatment promising for halting Huntingtons-related nerve death
4. Triple-drug therapy promising against African HIV subtype
5. Mayo Clinic researchers announce promising next generation treatments for multiple myeloma
6. Outpatient lung cancer procedure promising for inoperable disease
7. PET scanning promising in diagnosing cancer-related neurological disorders
8. Preliminary results are promising in Alzheimers gene therapy trial
9. Fertility herbal supplement sprouts promising results in Stanford pilot study
10. NIH researchers test promising new therapy for blinding eye disease
11. University Of Pittsburgh Medical Center studying promising new imaging technology

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/11/2019)... ... 11, 2019 , ... PatientPay, the leading end-to-end patient payment ... of a patent to reduce the level of effort a medical group must ... visit patient statements. , At the core of “Instant Integration for Installment Payments” ...
(Date:9/11/2019)... , ... September 11, 2019 , ... Executives at health ... of change in the healthcare industry over the past several years has been intense. ... worse. The future of healthcare in America will depend largely on how these executives ...
(Date:9/11/2019)... ... 2019 , ... Women’s Excellence is pleased to welcome Dr. ... highly skilled Obstetrician/Gynecologist. She approaches patients compassionately and offers comprehensive obstetrical and ... visit is comfortable, patient-focused, and that every patient feels her concerns have been ...
(Date:9/11/2019)... NEW YORK (PRWEB) , ... ... ... expertise of industry leaders to explore solutions to problems facing the ever-changing ... edition of their campaign, “Employee Benefits and Engagement.” With topics ranging from ...
(Date:9/11/2019)... , ... September 11, 2019 , ... Dimensional Insight®, ... the registration table at the annual St. Jude Walk/Run Boston. To be held on ... of participants to raise a goal of $650,000 for St. Jude Children’s Research ...
Breaking Medicine News(10 mins):
(Date:9/18/2019)... ... September 18, 2019 , ... U.S. Dermatology Partners was ... water swim Saturday, September 14th. The event took place at Lake Ray Hubbard ... and Jim Montgomery. The money raised helps fund phase 1 clinical trials ...
(Date:9/17/2019)... New Zealand (PRWEB) , ... September 17, 2019 , ... ... in in Fast Company’s 2019 Innovation by Design Awards Students category. , It was ... at the Auckland Bioengineering Institute. , Muss-Bits is comprised of two parts. A “sensor ...
(Date:9/17/2019)... , ... September 17, 2019 , ... ... proud to establish a new partnership with NextGen Healthcare Inc., a leading healthcare ... of partners, which include Nextech, DrChrono, Symplast and Azalea, with additional partnerships to ...
Breaking Medicine Technology:
Cached News: